当前位置： SCI文献检索 > PSYCHOSOMATIC MEDICINE期刊下所有文献 > Effect on disability outcomes of a depression relapse prevention program.

Effect on disability outcomes of a depression relapse prevention program.

Abstract：

OBJECTIVE:This report evaluates the effects of a depression relapse prevention program on disability outcomes among patients treated for depression at high risk for relapse. MATERIALS AND METHODS:Primary care patients initiating antidepressant treatment for depression were assessed 6 to 8 weeks after the initial prescription. Patients responding to initial treatment but at high risk for relapse were randomized to usual care or a relapse prevention intervention (N= 386). The 12-month relapse prevention program included systematic patient education, two psycho-educational visits with a depression prevention specialist, shared decision-making regarding maintenance pharmacotherapy, and ongoing monitoring of medication adherence and depressive symptoms via telephone and mail. Disability outcomes were assessed via blinded telephone assessments at 3, 6, 9, and 12 months using SF-36 and Sheehan Disability scales. RESULTS:Usual care patients and relapse prevention program patients had high rates of use of maintenance pharmacotherapy. Both relapse prevention and usual care patients showed improved functioning over the 12-month follow-up period. One of the three disability measures (the SF-36 Social Function scale) showed a significant intervention effect because of continuing improvement at 9 and 12 month follow-up, whereas the Sheehan Disability Scale showed a nonsignificant trend toward greater improvements in disability among relapse prevention patients than among usual care controls. CONCLUSIONS:Moderate effects of a relapse prevention intervention on depressive symptoms were associated with modest and variable effects on disability outcomes. Inconsistent effects of the intervention for disability outcomes may be because of the high rates of maintenance pharmacotherapy among usual care patients, relatively mild levels of depressive symptoms among both intervention and control patients at baseline, the absence of a specific relapse prevention effect of the intervention, and the resultant modest differences in depressive symptoms between intervention and control patients in this trial.

journal_name

Psychosom Med

journal_title

Psychosomatic medicine

authors

Von Korff M,Katon W,Rutter C,Ludman E,Simon G,Lin E,Bush T

doi

10.1097/01.psy.0000097336.95046.0c

subject

Has Abstract

pub_date

2003-11-01 00:00:00

pages

938-43

issue

eissn

0033-3174

issn

1534-7796

journal_volume

pub_type

临床试验,杂志文章,随机对照试验

在线工具

Effect on disability outcomes of a depression relapse prevention program.